Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

Study Questions:

Do plasma levels of fibroblast growth factor 23 (FGF-23) predict end-stage renal disease (ESRD) and mortality in patients with chronic kidney disease (CKD)?